Skip to Content

Arbutus Biopharma

ABUS

Buy $ABUS at eToro
Rank 4695
Country USA
Exchange NASDAQ
Currency USD
Sector LIFE SCIENCES
Industry PHARMACEUTICAL PREPARATIONS
Address 100-8900 GLENLYON PARKWAY, BURNABY, BC, CA

Arbutus Biopharma - Key figures

Market cap 374.88 Million
Revenue 33.37 Million
Profit -54,514,000
P/E Ratio No information
P/s Ratio 11.23
Buy $ABUS at eToro

Arbutus Biopharma - Description

Arbutus Biopharma Corporation, a biopharmaceutical company, is dedicated to the discovery, development, and commercialization of a cure for patients with chronic hepatitis B virus (HBV) infection in the United States.

The company is headquartered in Warminster, Pennsylvania.